Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Exelixis plans shuttering of East Coast site, 130 layoffs
The cancer company is closing its site in King of Prussia, Pennsylvania, to focus on operations in Alameda, California.
Darren Incorvaia
Aug 27, 2025 2:20pm
Sponsored
How Bottom-Up QC Improvements Fix Product Problems Before They Start
Aug 25, 2025 8:00am
Paul Allen research foundation unveils with $500M funding plan
Aug 27, 2025 11:59am
Amylyx discontinues rare neuro program after missing ph. 2 mark
Aug 27, 2025 10:40am
Wugen woos VCs, landing $115M to bring CAR-T therapy to market
Aug 27, 2025 8:10am
Sitala seals $670M deal for Fosun immune disease drug
Aug 26, 2025 2:44pm
More News
Fierce Biotech Layoff Tracker 2025: Exelixis, Indivior & more
Aug 27, 2025 2:30pm
Fierce Biotech Fundraising Tracker: Wugen, Arnatar & more
Aug 27, 2025 12:00pm
3D-printed orthopedic implant maker restor3d raises $104M
Aug 27, 2025 11:15am
Fierce Pharma
Massachusetts shed R&D, manufacturing workers in '24: report
Aug 27, 2025 9:34am